David Windley
Stock Analyst at Jefferies
(4.70)
# 774
Out of 4,693 analysts
804
Total ratings
59%
Success rate
9.6%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Downgraded: Hold | $330 → $307 | $283.06 | +8.46% | 65 | Aug 3, 2026 | |
| HUM Humana | Maintained: Buy | $235 → $624 | $394.88 | +58.02% | 69 | Jul 22, 2026 | |
| ELV Elevance Health | Maintained: Buy | $391 → $450 | $403.04 | +11.65% | 78 | Jul 16, 2026 | |
| MEDP Medpace Holdings | Downgraded: Hold | $490 → $515 | $583.21 | -11.70% | 35 | Jul 7, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $135 → $193 | $161.40 | +19.58% | 74 | Jun 25, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $225 | $282.34 | -20.31% | 75 | May 8, 2026 | |
| CNC Centene | Maintained: Hold | $43 → $39 | $65.23 | -40.21% | 88 | Apr 20, 2026 | |
| MOH Molina Healthcare | Maintained: Hold | $160 → $139 | $203.06 | -31.55% | 60 | Apr 20, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $340 → $373 | $396.30 | -5.88% | 73 | Apr 20, 2026 | |
| OSCR Oscar Health | Upgraded: Hold | $12 → $16 | $29.83 | -46.36% | 7 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $365 → $295 | $338.65 | -12.89% | 42 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $18 | $20.71 | -15.50% | 15 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 → $255 | $258.35 | -1.30% | 59 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $18.68 | +4.39% | 14 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $9.5 | $17.72 | -46.39% | 3 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $3 | $0.5362 | n/a | 2 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $263 | $229.65 | n/a | 2 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $335 | $279.23 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $15 | $8.10 | n/a | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $177 → $190 | $44.13 | n/a | 3 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 → $248 | $6.26 | n/a | 5 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8.5 | $4.81 | n/a | 10 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $4.28 | n/a | 4 | Aug 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $326.30 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $0.9448 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $1.15 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $187.58 | n/a | 1 | Nov 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $47.20 | n/a | 1 | Aug 27, 2009 |
The Cigna Group
Aug 3, 2026
Downgraded: Hold
Price Target: $330 → $307
Current: $283.06
Upside: +8.46%
Humana
Jul 22, 2026
Maintained: Buy
Price Target: $235 → $624
Current: $394.88
Upside: +58.02%
Elevance Health
Jul 16, 2026
Maintained: Buy
Price Target: $391 → $450
Current: $403.04
Upside: +11.65%
Medpace Holdings
Jul 7, 2026
Downgraded: Hold
Price Target: $490 → $515
Current: $583.21
Upside: -11.70%
ICON Public Limited Company
Jun 25, 2026
Reiterated: Buy
Price Target: $135 → $193
Current: $161.40
Upside: +19.58%
Charles River Laboratories International
May 8, 2026
Maintained: Buy
Price Target: $225
Current: $282.34
Upside: -20.31%
Centene
Apr 20, 2026
Maintained: Hold
Price Target: $43 → $39
Current: $65.23
Upside: -40.21%
Molina Healthcare
Apr 20, 2026
Maintained: Hold
Price Target: $160 → $139
Current: $203.06
Upside: -31.55%
UnitedHealth Group
Apr 20, 2026
Maintained: Buy
Price Target: $340 → $373
Current: $396.30
Upside: -5.88%
Oscar Health
Apr 20, 2026
Upgraded: Hold
Price Target: $12 → $16
Current: $29.83
Upside: -46.36%
Feb 10, 2026
Maintained: Buy
Price Target: $365 → $295
Current: $338.65
Upside: -12.89%
Feb 10, 2026
Maintained: Hold
Price Target: $21 → $18
Current: $20.71
Upside: -15.50%
Feb 6, 2026
Maintained: Buy
Price Target: $225 → $255
Current: $258.35
Upside: -1.30%
Nov 20, 2025
Maintained: Buy
Price Target: $16 → $20
Current: $18.68
Upside: +4.39%
Sep 8, 2025
Maintained: Hold
Price Target: $21 → $9.5
Current: $17.72
Upside: -46.39%
Aug 25, 2025
Maintained: Hold
Price Target: $2.75 → $3
Current: $0.5362
Upside: n/a
Jun 4, 2025
Maintained: Hold
Price Target: $263
Current: $229.65
Upside: n/a
Jun 2, 2025
Maintained: Buy
Price Target: $280 → $335
Current: $279.23
Upside: n/a
Apr 21, 2025
Maintained: Hold
Price Target: $16 → $15
Current: $8.10
Upside: n/a
Apr 26, 2021
Maintained: Buy
Price Target: $177 → $190
Current: $44.13
Upside: n/a
Feb 25, 2021
Maintained: Hold
Price Target: $200 → $248
Current: $6.26
Upside: n/a
Aug 4, 2020
Rated: Hold
Price Target: $7 → $8.5
Current: $4.81
Upside: n/a
Aug 21, 2017
Reiterated: Buy
Price Target: $28
Current: $4.28
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $129
Current: $326.30
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $9.5
Current: $0.9448
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $36
Current: $1.15
Upside: n/a
Nov 28, 2016
Reiterated: Hold
Price Target: $68
Current: $187.58
Upside: n/a
Aug 27, 2009
Downgraded: Hold
Price Target: $12
Current: $47.20
Upside: n/a